GLS and colorectal carcinoma: Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl sulfide (BPTES), CB-839, and compound 968 are glutaminase inhibitors that have been developed, and their inhibitory effects on CRC cell viability are compared.